Improved outcome of acute myeloid leukaemia in Down's syndrome.

Improved outcome of acute myeloid leukaemia in Down's syndrome.

OBJECTIVE: To review the clinical features, treatment, and outcome of children in the UK with Down's syndrome and acute myeloid leukaemia (AML). DESIGN: A retrospective study of 59 children with Down's syndrome and AML presenting between 1987 and 1995. Data were obtained from hospital case...

Descripció completa

Dades bibliogràfiques
Autors principals:	Craze, J, Harrison, G, Wheatley, K, Hann, I, Chessells, J
Format:	Journal article
Idioma:	English
Publicat:	1999

Ítems similars

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
per: Chessells, J, et al.
Publicat: (2002)

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
per: Chessells, J, et al.
Publicat: (2001)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
per: Eden, O, et al.
Publicat: (1998)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
per: Webb, D, et al.
Publicat: (1999)

Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
per: Phillips, M, et al.
Publicat: (1991)

EVI1 expression in acute myeloid leukaemia.
per: Langabeer, SE, et al.
Publicat: (2001)

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
per: Burnett, A, et al.
Publicat: (2002)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
per: Garnett, C, et al.
Publicat: (2019)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
per: R Edlin, et al.
Publicat: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
per: R Edlin, et al.
Publicat: (2010-05-01)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
per: Eden, O, et al.
Publicat: (2000)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
per: Boultwood, J, et al.
Publicat: (2004)

Chronic myeloid leukaemia with pulmonary leucostasis in a young Down syndrome patient
per: Mohd Jazman bin Che Rahim, et al.
Publicat: (2020-09-01)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
per: Nighat Shahbaz, et al.
Publicat: (2020-10-01)

OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
per: Nighat Shahbaz, et al.
Publicat: (2020-10-01)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
per: Guinn, B, et al.
Publicat: (2005)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
per: Patrick, K, et al.
Publicat: (2014)

Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol
per: Patrick, K, et al.
Publicat: (2014)

Remission death in acute lymphoblastic leukaemia: a changing pattern.
per: Atra, A, et al.
Publicat: (1993)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
per: Christine S. Young, et al.
Publicat: (2015-06-01)

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
per: Chessells, J, et al.
Publicat: (2002)

Acute Myeloid Leukaemia with Plasmacytosis
per: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Publicat: (2016-12-01)

Exploring the acute myeloid leukaemias
per: TB Thapa
Publicat: (2013-10-01)

Haematopoietic development and leukaemia in Down syndrome
per: Roberts, I, et al.
Publicat: (2014)

Orbital deposit in acute myeloid leukaemia
per: Seal G, et al.
Publicat: (1973-01-01)

Comparison of bone marrow transplantation with chemotherapy for high risk childhood acute lymphoblastic leukaemia in first remission.
per: Wheeler, K, et al.
Publicat: (1998)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
per: Vyas, P, et al.
Publicat: (2007)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1997)

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
per: Roy, A, et al.
Publicat: (2009)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
per: Eden, O, et al.
Publicat: (2000)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
per: Lilleyman, J, et al.
Publicat: (1992)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
per: Goh, Chermaine Yu Zhen
Publicat: (2021)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
per: Boultwood, J, et al.
Publicat: (1996)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
per: Sweeney, C
Publicat: (2021)

Immunological weapons against acute myeloid leukaemia.
per: Galea-Lauri, J
Publicat: (2002)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
per: Xinping Zhou, et al.
Publicat: (2023-07-01)

Adhesion Deregulation in Acute Myeloid Leukaemia
per: Alicja M. Gruszka, et al.
Publicat: (2019-01-01)

Wnt Signalling in Acute Myeloid Leukaemia
per: Alicja M. Gruszka, et al.
Publicat: (2019-11-01)

Genes located within the del(9q) commonly deleted region are down-regualted in acute myeloid leukaemia.
per: Zhao, Z, et al.
Publicat: (2004)

Our treatment experience with azacytidine in patients with acute myeloid leukaemia, chronic myelomonocytic leukaemia and myelodysplastic syndrome
per: Peter Černelč, et al.
Publicat: (2012-12-01)